In an “in vivo study”, SOX2 expression in HNSCC tumor cells led to a decrease in CD8+ T-lymphocyte infiltration and promoted tumor growth through the suppression of stimulation of interferon genes (STING)-dependent interferon-I-mediated signaling. This evidence concerns the gene STING1 and neoplasm.